Osaka, Japan

Fumitaka Katoh

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumitaka Katoh. Retrieved from https://idiyas.com/inventor/fumitaka-katoh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumitaka Katoh: Innovator in Neovascularization Inhibition

Introduction

Fumitaka Katoh is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of medical innovations, particularly in the area of neovascularization inhibitors. His work has the potential to impact various therapeutic applications.

Latest Patents

Fumitaka Katoh holds a patent for a neovascularization inhibitor. This invention is crucial in addressing conditions related to abnormal blood vessel growth, which can lead to various health complications. His innovative approach in this area showcases his commitment to advancing medical science.

Career Highlights

Katoh is associated with Nippon Shinyaku Company, Ltd., where he continues to contribute to research and development. His role in the company allows him to collaborate with other experts in the field, enhancing the impact of his inventions.

Collaborations

Fumitaka Katoh has worked alongside his coworker, Fusao Ueda, to further explore advancements in their respective fields. Their collaboration exemplifies the importance of teamwork in driving innovation.

Conclusion

Fumitaka Katoh is a dedicated inventor whose work in neovascularization inhibitors represents a significant advancement in medical technology. His contributions at Nippon Shinyaku Company, Ltd. highlight the importance of innovation in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…